Home > Insider Trading > Alimera Sciences Inc

Alimera Sciences Inc (ALIM)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

13D Filing: Intersouth Partners VI LP and Alimera Sciences Inc (ALIM)

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information...

Keep Reading →

June 9th, 2017 - Hedge Funds

Is Alimera Sciences Inc (ALIM) A Good Stock To Buy?

At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively...

Keep Reading →

December 18th, 2016 - Hedge Funds News

Alimera Sciences Inc (ALIM): Great Point Partners Reveals 5.12% Stake

Jeffrey Jay and David Kroin's Great Point Partners reported the acquisition of 3.25 million common shares of Alimera Sciences Inc (NASDAQ:ALIM) which account for 5.12% of the company's outstanding stock...

Keep Reading →

August 23rd, 2016 - Hedge Funds News

Tempur Sealy (TPX), GrubHub (GRUB), United States Steel Corporation (X) Among Top Weekly Gainers

It was a mixed week for the market last week, as the Dow gave up 0.75% of its value, while the S&P 500 was down slightly, and the Nasdaq was 1.21% in the green.

Keep Reading →

July 31st, 2016 - Market Movers News

Tiger Global Cuts Stake in Autohome, While Deerfield Buys More Shares of This Pharmaceutical Company

Federal funds future contracts suggest a 79% probability that the Federal Reserve will raise interest rates at the December policy meeting, an event which is expected to halt the U.S equities lengthy...

Keep Reading →

December 9th, 2015 - Hedge Funds News

Three Healthcare Stocks Hedge Funds Are Snapping Up

Is it a good time to buy Alimera Sciences Inc (NASDAQ:ALIM)? James E. Flynn thinks so, having recently acquired 321,784 shares of the pharmaceutical company at prices ranging from $2.10-to-$2.50.

Keep Reading →

October 15th, 2015 - Hedge Funds News

Jeffrey Ray's Great Point Partners Trims Its Stake In Alcobra Ltd (ADHD)

Jeffrey Jay and David Kroin's healthcare-focused fund, Great Point Partners, decreased its passive stake in the Israel based biopharmaceutical company, Alcobra Ltd (NASDAQ:ADHD), according to a recent...

Keep Reading →

April 22nd, 2015 - Hedge Funds News

Connecture Inc (CNXR), Hyperion Therapeutics Inc (HPTX): Top 5 Healthcare Picks of Great Point Partners

Jeffrey Jay and David Kroin’s Great Point Partners is one of the newer funds we track at Insider Monkey, and we’ll cover the healthcare-focused fund’s top picks for the first time.

Keep Reading →

March 2nd, 2015 - Hedge Funds News

Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy

Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E.

Keep Reading →

November 3rd, 2014 - Hedge Funds News

Alimera Sciences Inc (ALIM) & Bio Blast Pharma Ltd (ORPN): 2 Pharmaceutical Stocks Hedge Funds are Increasing Their Stakes In

Pharmaceuticals and life sciences as a sector is where most of the money from hedge funds seems to be flowing in. However, it’s the sector-specific funds that are making the big purchases.

Keep Reading →

October 20th, 2014 - Hedge Funds News